Noninvasive biomarkers with diagnostic value and prognostic applications have long been
desired to replace muscle biopsy for Duchenne muscular dystrophy (DMD) patients …

Creatine kinase has been utilized as a diagnostic marker for Duchenne muscular dystrophy
(DMD), but it correlates less well with the DMD pathological progression. In this study, we …

Circulating microRNAs (miRs/miRNAs) are being used as non-invasive biomarkers for
diagnosis, prognosis and efficiency of clinical trials. However, to exploit their potential it is …

The discovery of reliable and sensitive blood biomarkers is useful for the diagnosis,
monitoring and potential future therapy of diseases. Recently, microRNAs (miRNAs) have …

miRNAs are small, noncoding RNAs that not only regulate gene expression within cells, but
might also constitute promising extracellular biomarkers for a variety of pathologies …

Our objective was to investigate the potential of three microRNAs, miR-181a-5p, miR-30c-
5p, and miR-206 as prognostic biomarkers for long-term follow up of Duchenne muscular …

Duchenne muscular dystrophy (DMD) is a lethal X-linked disorder caused by mutations in
the dystrophin gene, which encodes a cytoskeletal protein, dystrophin. Creatine kinase (CK) …

Abstract Myotonic dystrophy type 1 (DM1) is the most common form of adult-onset muscular
dystrophy, which is characterised by progressive muscle wasting and the discovery of …

Duchenne muscular Dystrophy (DMD) is an inherited disease caused by mutations in the
dystrophin gene that disrupt the open reading frame, while in frame mutations result in …

Duchenne muscular dystrophy (DMD) is an X-linked recessive genetic disorder caused by
out of frame mutations in the dystrophin gene. The hallmark symptoms of the condition …